Literature DB >> 16997382

The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal.

Marco Mula1, Stefano Pini, Giovanni B Cassano.   

Abstract

Depersonalization and derealization occur on a continuum of situations, from healthy individuals to a severely debilitating disorder where the symptoms can persist chronically. Since 1960s, different neurobiological models have been hypothesized and they have been associated with the temporal lobes. Recent advances in the functioning of the limbic system and the application of Geschwind's concept of disconnection in the cortico-limbic networks, pointed the role of the amygdala and its connections with medial prefrontal cortex and anterior cingulate cortex, the same structures that are strictly interlinked with the neurobiology of emotions and affective disorders. In this paper, we hypothesize that depersonalization may represent a clinical index of disease severity, poorer response to treatment and high level of comorbidity, in mood and anxiety disorders, discussing the neurobiology of depersonalization and the available clinical evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16997382     DOI: 10.1016/j.jad.2006.08.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

Review 1.  [Delusional depression : Diagnostics, phenomenology and therapy].

Authors:  M Bürgy
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

2.  Prevalence and correlates of depersonalization in students aged 12-18 years in Germany.

Authors:  Matthias Michal; Eva Duven; Sebastian Giralt; Michael Dreier; Kai W Müller; Julia Adler; Manfred E Beutel; Klaus Wölfling
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-09-09       Impact factor: 4.328

3.  Bilaterally reduced claustral volumes in schizophrenia and major depressive disorder: a morphometric postmortem study.

Authors:  Hans-Gert Bernstein; Anna Ortmann; Henrik Dobrowolny; Johann Steiner; Ralf Brisch; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-31       Impact factor: 5.270

4.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

5.  [On the differential diagnostics of depersonalization experiences].

Authors:  M Bürgy
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

6.  Interoceptive-reflective regions differentiate alexithymia traits in depersonalization disorder.

Authors:  Erwin Lemche; Michael J Brammer; Anthony S David; Simon A Surguladze; Mary L Phillips; Mauricio Sierra; Steven C R Williams; Vincent P Giampietro
Journal:  Psychiatry Res       Date:  2013-08-07       Impact factor: 3.222

7.  Validity and reliability of the Structured Clinical Interview for Depersonalization-Derealization Spectrum (SCI-DER).

Authors:  Marco Mula; Stefano Pini; Simona Calugi; Matteo Preve; Matteo Masini; Ilaria Giovannini; Ciro Conversano; Paola Rucci; Giovanni B Cassano
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

8.  Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria.

Authors:  Ewa A Ogłodek; Anna M Szota; Marek J Just; Aleksander Araszkiewicz; Adam R Szromek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-21       Impact factor: 2.570

9.  Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.

Authors:  Christian G Bien
Journal:  Front Immunol       Date:  2018-04-11       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.